Scarica l'app Stockscreener
3.38
1.81%
0.06
Dopo l'orario di chiusura:
3.25
-0.13
-3.85%
Nrx Pharmaceuticals Inc Borsa (NRXP) Ultime notizie
New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Joplin Globe
NRx Pharmaceuticals (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners - financial-news.co.uk
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners - StreetInsider
NRx Pharmaceuticals Taps Top Biotech IR Firm ahead of Critical FDA Filings and Clinic Acquisitions - Stock Titan
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP) - Livingston Daily
Safety scares and trial misses drag down neuro biotechs into Q2 - BioWorld MedTech
NRx Pharmaceuticals CEO Set to Reveal Latest Advances at Major Neuroscience Investment Conference - Stock Titan
Squarepoint Ops LLC Makes New Investment in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) - Defense World
NRX Pharmaceuticals Submits FDA Application for NRX-100 - TipRanks
New to The Street Signs National Media Agreement with NRx Pharmaceuticals for 12-Part Broadcast Series Across TV, Digital, and Outdoor Platforms - USA Today
NRx Pharmaceuticals’ (NRXP) Buy Rating Reaffirmed at D. Boral Capital - Defense World
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network - Yahoo Finance
NRx Pharmaceuticals (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network - Barchart.com
NRX Pharmaceuticals: Strategic Positioning and Market Potential Drive Buy Rating - TipRanks
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025 - mx.advfn.com
NRx Pharmaceuticals files for preservative-free ketamine By Investing.com - Investing.com South Africa
$750 Million Market Projected to Reach $3.35 Billion Globally - openPR.com
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine - Yahoo Finance
Why Ciena Stock Is Plummeting Today - The Globe and Mail
$750 Million Market Projected to Reach $3.35 Billion Globally in 2034 for Abbreviated New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
$750 Million Market Projected to Reach $3.35 Billion Globally in 2034 for Abbreviated New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) | FinancialContent - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine - TipRanks
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Abbreviated New Drug Application (ANDA) for Preservative-Free IV Ketamine - GuruFocus
NRx Pharmaceuticals files for preservative-free ketamine - Investing.com Australia
NRXP Advances FDA Application for IV Ketamine With Preservative-Free Formulation | NRXP Stock News - GuruFocus
NRX Pharmaceuticals Seeks FDA's Priority Review for Preservative-Free IV Ketamine - MarketScreener
Why Overall Consumer Confidence Is Critical to the Markets You Follow - The Globe and Mail
Public market insider buying at Tourmaline Oil (TOU) - The Globe and Mail
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network - MSN
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval - Yahoo Finance
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval - TipRanks
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition - Yahoo Finance
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition - financial-news.co.uk
Analysts Set NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Target Price at $28.50 - Defense World
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN
NRX Pharmaceuticals Announces $7.8M Debt Financing Deal - TipRanks
NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21 - financial-news.co.uk
IBN Coverage: NRx Pharmaceuticals (NASDAQ: NRXP) to Present at Wall Street Conference on May 21 - Yahoo Finance
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):